Korean J Gastroenterol.  2017 Apr;69(4):203-205. 10.4166/kjg.2017.69.4.203.

Fecal Microbiota Transplantation as a Treatment of Recurrent Clostridium difficile Infection: Where Are We Now and Where Are We Heading?

• Shin YJ
• Lee BJ

• KMID: 2383396
• DOI: http://doi.org/10.4166/kjg.2017.69.4.203

Abstract

No abstract available.

MeSH Terms

Clostridium difficile*
Clostridium*
Fecal Microbiota Transplantation*
Head*

Reference

1. Austin M, Mellow M, Tierney WM. Fecal microbiota transplantation in the treatment of clostridium difficile infections. Am J Med. 2014; 127:479–483.

2. Kim J, Pai H, Seo MR, Kang JO. Epidemiology and clinical characteristics of clostridium difficile infection in a Korean tertiary hospital. J Korean Med Sci. 2011; 26:1258–1264.

3. Brandt LJ, Aroniadis OC, Mellow M, et al. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent clostridium difficile infection. Am J Gastroenterol. 2012; 107:1079–1087.

4. Mattila E, Uusitalo-Seppälä R, Wuorela M, et al. Fecal transplantation, through colonoscopy, is effective therapy for recurrent clostridium difficile infection. Gastroenterology. 2012; 142:490–496.

5. Bouza E. Consequences of clostridium difficile infection: understanding the healthcare burden. Clin Microbiol Infect. 2012; 18:Suppl 6. 5–12.

6. Eiseman B, Silen W, Bascom GS, Kauvar AJ. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery. 1958; 44:854–859.

7. Cammarota G, Ianiro G, Gasbarrini A. Fecal microbiota transplantation for the treatment of clostridium difficile infection: a systematic review. J Clin Gastroenterol. 2014; 48:693–702.

8. Khoruts A, Dicksved J, Jansson JK, Sadowsky MJ. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent clostridium difficile-associated diarrhea. J Clinical Gastroenterol. 2010; 44:354–360.

9. Bang BW, Park JS, Kim HK, et al. Fecal microbiota transplantation for refractory and recurrent clostridium difficile infection: a case series of nine patients. Korean J Gastroenterol. 2017; 69:226–231.

10. Bakken JS, Borody T, Brandt LJ, et al. Treating clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol. 2011; 9:1044–1049.

11. Kelly CR, Ihunnah C, Fischer M, et al. Fecal microbiota transplant for treatment of clostridium difficile infection in immunocompromised patients. Am J Gastroenterol. 2014; 109:1065–1071.

12. Debast SB, Bauer MP, Kuijper EJ. European Society of Clinical Microbiology and Infectious Diseases. European society of clinical microbiology and infectious diseases: update of the treatment guidance document for clostridium difficile infection. Clin Microbiol Infect. 2014; 20:Suppl 2. 1–26.

13. Surawicz CM, Brandt LJ, Binion DG, et al. Guidelines for diagnosis, treatment, and prevention of clostridium difficile infections. Am J Gastroenterol. 2013; 108:478–498. quiz 499.

14. Youngster I, Russell GH, Pindar C, Ziv-Baran T, Sauk J, Hohmann EL. Oral, capsulized, frozen fecal microbiota transplantation for relapsing clostridium difficile infection. JAMA. 2014; 312:1772–1778.

15. Vrieze A, de Groot PF, Kootte RS, Knaapen M, van Nood E, Nieuwdorp M. Fecal transplant: a safe and sustainable clinical therapy for restoring intestinal microbial balance in human disease? Best Pract Res Clin Gastroenterol. 2013; 27:127–137.